TG Therapeutics got orphan drug designation from the FDA for both its clinical candidates this week.

Gobiquity, which markets a smartphone vision screening app, reeled in $6 million in a first close of its Series B round.

Struggling microcap GenVec has again been warned that it will be taken off the lucrative and respected Nasdaq exchange if it doesn’t get itself out of the…

Muddy Waters Research had a few words regarding St. Jude Medical in a recent report. The short seller made predictions regarding the devicemaker’s revenue and…

Investors have plowed another $130 million into a Series B to back the startup that’s led by Genentech vets, which brings its total raised to almost $350…

BioLineRx has teamed up with I-Bridge Capital to set up a Chinese drug development joint venture, iPharma.

The late-stage skin condition biotech Novan is looking to batter ongoing headwinds and gun for a $60 million public offering.

In the same week that Medivation was bought out by Pfizer in a major $14 billion deal, its former vice president of clinical development Dr. Amy Peterson has…